Skip to main content
SpringerLink
Log in

Anxiolytika und Hypnotika

  • Chapter
Handbuch der psychiatrischen Pharmakotherapie

Zusammenfassung

Schon zu Urzeiten nutzten Menschen natürliche und artifizielle Mittel zur Anxiolyse und als Hypnotika. So ist bekannt, dass die Sumerer vor mehr als 7000 Jahren Opium einsetzten, wenn vielleicht auch mehr als Analgetikum oder in kultischen Handlungen. Die ersten schriftlichen Rezepte des Bierbrauens sind von 3500 v. Chr. auf einem ägyptischen Papyrus überliefert, während entsprechende Reinheitsgebote aus babylonischer Zeit bekannt sind. Zwar galt Bier im Wesentlichen als ein Nahrungsmittel, es wurde aber auch wegen seiner anxiolytischen und hypnotischen Eigenschaften geschätzt.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Aldhous M, Franey C, Wright J, Arendt J (1985) Plasma concentrations of melatonin in man following oral absorption of different preparations. Br J Clin Pharmacol 19: 517–521

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Arbilla S, Allen J, Wick A, Langer SZ (1986) High affinity [3H]zolpidem binding in the rat brain: an imidazopyridine with agonist properties at central benzodiazepine receptors. Eur J Pharmacol 130: 257–263

    Article  CAS  PubMed  Google Scholar 

  • Atack JR (2010a) GABAA receptor α2/α3 subtype-selective modulators as potential nonsedating anxiolytics. Curr Top Behav Neurosci 2: 331–360

    Article  PubMed  Google Scholar 

  • Atack JR (2010b) Preclinical and clinical pharmacology of the GABAA receptor α5 subtype-selective inverse agonist α5IA. Pharmacol Ther 125: 11–26

    Article  CAS  PubMed  Google Scholar 

  • Bailey DN, Briggs JR (2002) Carisoprodol: an unrecognized drug of abuse. Am J Clin Pathol 117: 396–400

    Article  CAS  PubMed  Google Scholar 

  • Baldwin DS, Polkinghorn C (2005) Evidence-based pharmacotherapy of generalized anxiety disorder. Int J Neuropsychopharmacol 8: 293–302

    Article  CAS  PubMed  Google Scholar 

  • Battaglia J (2005) Pharmacological management of acute agitation. Drugs 65: 1207–1222

    Article  CAS  PubMed  Google Scholar 

  • Benavides J, Peny B, Dubois A et al (1988) In vivo interaction of zolpidem with central benzodiazepine (BZD) binding sites (as labeled by [3H]Ro 15–1788) in the mouse brain. Preferential affinity of zolpidem for the ω1 (BZD1) subtype. J Pharmacol Exp Ther 245: 1033–1041

    CAS  PubMed  Google Scholar 

  • Berman ME, Jones GD, McCloskey MS (2005) The effects of diazepam on human self-aggressive behavior. Psychopharmacology (Berl) 178: 100–106

    Article  CAS  Google Scholar 

  • Bhatnagar S, Sun LM, Raber J et al (2004) Changes in anxiety-related behaviors and hypothalamic-pituitary-adrenal activity in mice lacking the 5-HT-3A receptor. Physiol Behav 81: 545–555

    Article  CAS  PubMed  Google Scholar 

  • Birnir B, Tierney ML, Lim M et al (1997) Nature of the 5‘ residue in the M2 domain affects function of the human α1β1 GABAA receptor. Synapse 26: 324–427

    Article  CAS  PubMed  Google Scholar 

  • Boehm SL 2nd, Ponomarev I, Jennings AW et al (2004a) γ-Aminobutyric acid A receptor subunit mutant mice: new perspectives on alcohol actions. Biochem Pharmacol 68: 1581–1602

    Article  CAS  PubMed  Google Scholar 

  • Boehm SL II, Peden L, Harris RA, Blednov YA (2004b) Deletion of the fyn-kinase gene alters sensitivity to GABAergic drugs: dependence on β2/β3 GABAA receptor subunits. J Pharmacol Exp Ther 309: 1154–1159

    Article  CAS  PubMed  Google Scholar 

  • Bogaards JJ, Hissink EM, Briggs M et al (2000) Prediction of interindividual variation in drug plasma levels in vivo from individual enzyme kinetic data and physiologically based pharmacokinetic modeling. Eur J Pharm Sci 12: 117–124

    Article  CAS  PubMed  Google Scholar 

  • Bonnet U (2003) Moclobemide: therapeutic use and clinical studies. CNS Drug Rev 9: 97–140

    Article  CAS  PubMed  Google Scholar 

  • Bramness JG, Skurtveit S, Morland J (2004) Impairment due to intake of carisoprodol. Drug Alcohol Depend 74: 311–318

    Article  CAS  PubMed  Google Scholar 

  • Brandon NJ, Uren JM, Kittler JT et al (1999) Subunit-specific association of protein kinase C and the receptor for activated C kinase with GABA type A receptors. J Neurosci 19: 9228–9234

    CAS  PubMed  Google Scholar 

  • Brandon N, Jovanovic J, Moss S (2002) Multiple roles of protein kinases in the modulation of gamma-aminobutyric acid(A) receptor function and cell surface expression. Pharmacol Ther 94: 113–122

    Article  CAS  PubMed  Google Scholar 

  • Carta M, Mameli M, Valenzuela CF (2004) Alcohol enhances GABAergic transmission to cerebellar granule cells via an increase in Golgi cell excitability. J Neurosci 24: 3746–3751

    Article  CAS  PubMed  Google Scholar 

  • Churn SB, Rana A, Lee K et al (2002) Calcium/calmodulin-dependent kinase II phosphorylation of the GABAA receptor α1 subunit modulates benzodiazepine binding. J Neurochem 82: 1065–1076

    Article  CAS  PubMed  Google Scholar 

  • Davidson JR (2004) Use of benzodiazepines in social anxiety disorder, generalized anxiety disorder, and posttraumatic stress disorder. J Clin Psychiatry 65(Suppl 5): 29–33

    CAS  PubMed  Google Scholar 

  • Demyttenaere K, Bonnewyn A, Bruffaerts R et al (2008) Clinical factors influencing the prescription of antidepressants and benzodiazepines: results from the European study of the epidemiology of mental disorders (ESEMeD). J Affect Disord 110: 84–93

    Article  PubMed  Google Scholar 

  • Dunne EL, Moss SJ, Smart TG (1998) Inhibition of GABAA receptor function by tyrosine kinase inhibitors and their inactive analogues. Mol Cell Neurosci 12: 300–310

    Article  CAS  PubMed  Google Scholar 

  • European Medicines Agency (2011) Summary of product characteristics Lyrica (pregabalin). 17/06/2011 Lyrica -EMEA/H/C/000546 -II/0045. www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Summary_for_the_public/human/000546/WC500046603.pdf

  • French JS, Coon MJ (1979) Properties of NADPH-cytochrome P-450 reductasepurified from rabbit liver microsomes. Arch Biochem Biophys 195: 565–577

    Google Scholar 

  • Hanchar HJ, Dodson PD, Olsen RW et al (2005) Alcohol-induced motor impairment caused by increased extrasynaptic GABAA receptor activity. Nature Neurosci 8: 339–345

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Hardeland R, Cardinali DP, Srinivasan V et al (2011) Melatonin – a pleiotropic, orchestrating regulator molecule. Prog Neurobiol 93: 350–384

    Article  CAS  PubMed  Google Scholar 

  • Herring BE, McMillan K, Pike CM et al (2011) Etomidate and propofol inhibit the neurotransmitter release machinery at different sites. J Physiol 589: 1103–1115

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Hickie IB, Rogers NL (2011) Novel melatonin-based therapies: potential advances in the treatment of major depression. Lancet 378: 621–631

    Article  CAS  PubMed  Google Scholar 

  • Hiemke C, Baumann P, Bernemann N et al (2011) AGNP Consensus Guidelines for Therapeutic Drug Monitoring in Psychiatry Update 2011. Pharmacopsychiatry 44: 195–235

    Article  Google Scholar 

  • Holzbach R, Martens M, Kalke J, Raschke P (2010) Zusammenhang zwischen Verschreibungsverhalten der Arzte und Medikamentenabhangigkeit ihrer Patienten. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 53: 319–325

    Article  CAS  PubMed  Google Scholar 

  • Houston CM, He Q, Smart TG (2009) CaMKII phosphorylation of the GABAA receptor: receptor subtype- and synapse-specific modulation. J Physiol 587: 2115–2125

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Jin P, Zhang J, Rowe-Teeter C et al (2004) Cloning and characterization of a GABAA receptor γ2 subunit variant. J Biol Chem 279: 1408–1414

    Article  CAS  PubMed  Google Scholar 

  • Jochemsen R, Breimer D (1984) Pharmacokinetics of benzodiazepines: metabolic pathways and plasma level profiles. Curr Med Res Opin 8(Suppl 4): 60–79

    Article  CAS  PubMed  Google Scholar 

  • Johnston GA, Curtis DR, Beart PM et al (1975) Cis- and trans-4-aminocrotonic acid as GABA analogues of restricted conformation. J Neurochem 24: 157–160

    Article  CAS  PubMed  Google Scholar 

  • Kelley SP, Bratt AM, Hodge CW (2003) Targeted gene deletion of the 5-HT3A receptor subunit produces an anxiolytic phenotype in mice. Eur J Pharmacol 461: 19–25

    Article  CAS  PubMed  Google Scholar 

  • Kirkness EF, Bovenkerk CF, Ueda T, Turner AJ (1989) Phosphorylation of γ- aminobutyrate (GABA)/benzodiazepine receptors by cyclic AMP-dependent protein kinase. Biochem J 259: 613–616

    PubMed Central  CAS  PubMed  Google Scholar 

  • Klein E, Colin V, Stolk J, Lenox RH (1994) Alprazolam withdrawal in patients with panic disorder and generalized anxiety disorder: vulnerability and effect of carbamazepine. Am J Psychiatry 151: 1760–1766

    Article  CAS  PubMed  Google Scholar 

  • Korpi ER, Debus F,Linden AM et al (2007) Does ethanol act preferentially via selected brain GABAA receptor subtypes? The current evidence is ambiguous. Alcohol 41: 163–176

    Article  CAS  PubMed  Google Scholar 

  • Li Z, Taylor CP, Weber M et al (2011) Pregabalin is a potent and selective ligand for α2δ-1 and α2δ-2 calcium channel subunits. Eur J Pharmacol 667: 80–90

    Article  CAS  PubMed  Google Scholar 

  • Linden AM, Schmitt U, Leppä E et al (2011) Ro 15–4513 antagonizes alcoholinduced sedation in mice through αβγ2-type GABAA receptors. Front Neurosci 5: 3

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • McDonald BJ, Amato A, Connolly CN et al (1998) Adjacent phosphorylation sites on GABAA receptor β subunits determine regulation by cAMP-dependent protein kinase. Nature Neurosci 1: 23–28

    Article  CAS  PubMed  Google Scholar 

  • McKernan RM, Whiting PJ (1996) Which GABAA-receptor subtypes really occur in the brain? Trends Neurosci 19: 139–143

    Article  CAS  PubMed  Google Scholar 

  • McKernan RM, Rosahl TW, Reynolds DS et al (2000) Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABAA receptor α1 subtype. Nature Neurosci 3: 587–592

    Article  CAS  PubMed  Google Scholar 

  • Mihalek RM, Bowers BJ, Wehner JM et al (2001) GABAA-receptor δ subunit knockout mice have multiple defects in behavioral responses to ethanol. Alcohol Clin Exp Res 25: 1708–1718

    CAS  PubMed  Google Scholar 

  • Millan MJ, Brocco M, Gobert A, Dekeyne A (2005) Anxiolytic properties of agomelatine, an antidepressant with melatoninergic and serotonergic properties: role of 5-HT2C receptor blockade. Psychopharmacology (Berl) 177: 448–458

    Article  CAS  Google Scholar 

  • Miller LG, Deutsch SI, Greenblatt DJ et al (1988) Acute barbiturate administration increases benzodiazepine receptor binding in vivo. Psychopharmacology (Berl) 96: 385–390

    Article  CAS  Google Scholar 

  • Miyasaka LS, Atallah AN, Soares BG (2006) Valerian for anxiety disorders. Cochrane Database Syst Rev 4: CD004515

    PubMed  Google Scholar 

  • Mullins CD, Shaya FT, Meng F et al (2005) Persistence, switching, and discontinuation rates among patients receiving sertraline, paroxetine, and citalopram. Pharmacotherapy 25: 660–667

    Article  PubMed  Google Scholar 

  • Nistri A, Sivilotti L (1985) An unusual effect of γ-aminobutyric acid on synaptic transmission of frog tectal neurones in vitro. Br J Pharmacol 85: 917–921

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Ntais C, Pakos E, Kyzas P, Ioannidis J (2005) Benzodiazepines for alcohol withdrawal. Cochrane Database Syst Rev, CD005063

    Google Scholar 

  • Nury H, van Renterghem C, Weng Y et al (2011) X-ray structures of general anaesthetics bound to a pentameric ligand-gated ion channel. Nature 469: 428–431

    Article  CAS  PubMed  Google Scholar 

  • Ohlson J, Pedersen JS, Haussler D, Öhman M (2007) Editing modifies the GABAA receptor subunit α3. RNA 13: 698–703

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Parks CL, Robinson PS, Sibille E et al (1998) Increased anxiety of mice lacking the serotonin 1A receptor. Proc Natl Acad Sci USA 95: 10734–10739

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Pirker S, Schwarzer C, Wieselthaler A et al (2000) GABAA receptors: immunocytochemical distribution of 13 subunits in the adult rat brain. Neuroscience 101: 815–850

    Article  CAS  PubMed  Google Scholar 

  • Pols HJ, Griez E, Zandbergen J (1989) Does buspirone have anxiogenic properties? Lancet 2: 682–683

    Article  CAS  PubMed  Google Scholar 

  • Pritchett DB, Lüddens H, Seeburg PH (1989) Type I and type II GABAA-benzodiazepine receptors produced in transfected cells. Science 245: 1389–1392

    Article  CAS  PubMed  Google Scholar 

  • Quintero JE, Dooley DJ, Pomerleau F et al (2011) Amperometric measurement of glutamate release modulation by gabapentin and pregabalin in rat neocortical slices: role of voltage-sensitive Ca2 +α2δ-1 subunit. J Pharmacol Exp Ther 338: 240–245

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Reeves RR, Beddingfield JJ, Mack JE (2004) Carisoprodol withdrawal syndrome. Pharmacotherapy 24: 1804–1806

    Article  PubMed  Google Scholar 

  • Rho JM,Donevan SD, Rogawski MA (1997) Barbiturate-like actions of the propanediol dicarbamates felbamate and meprobamate. J Pharmacol Exp Ther 280: 1383–1391

    CAS  PubMed  Google Scholar 

  • Ruano D, Benavides J, Machado A, Vitorica J (1993) Regional differences in the enhancement by GABA of [3H]zolpidem binding to ω1 sites in rat brain membranes and sections. Brain Res 600: 134–140

    Article  CAS  PubMed  Google Scholar 

  • Rudolph U, Crestani F, Benke D et al (1999) Benzodiazepine actions mediated by specific γ-aminobutyric acidA receptor subtypes. Nature 401: 796–800

    Article  CAS  PubMed  Google Scholar 

  • Rupprecht R (2003) Neuroactive steroids: mechanisms of action and neuropsychopharmacological properties. Psychoneuroendocrinology 28: 139–168

    Article  CAS  PubMed  Google Scholar 

  • San L, Arranz B, Escobar R (2005) Pharmacological management of acutely agitated schizophrenic patients. Curr Pharm Des 11: 2471–2477

    Article  CAS  PubMed  Google Scholar 

  • Sarris J, Byrne GJ (2011) A systematic review of insomnia and complementary medicine. Sleep Med Rev 15: 99–106

    Article  PubMed  Google Scholar 

  • Schubert B, Pavlic M, Libiseller K, Oberacher H (2008) Unraveling the metabolic transformation of tetrazepam to diazepam with mass spectrometric methods. Anal Bioanal Chem 392: 1299–1308

    Article  CAS  PubMed  Google Scholar 

  • Schofield PR, Darlison MG, Fujita N et al (1987) Sequence and functional expression of the GABAA receptor shows a ligand-gated receptor superfamily. Nature 328: 221–227

    Article  CAS  PubMed  Google Scholar 

  • Serafini R, Bracamontes J, Steinbach JH (2000) Structural domains of the human GABAA receptor β3 subunit involved in the actions of pentobarbital. J Physiol 524(Pt 3): 649–676

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Shivers BD, Killisch I, Sprengel R et al (1989) Two novel GABAA receptor subunits exist in distinct neuronal subpopulations. Neuron 3: 327–337

    Article  CAS  PubMed  Google Scholar 

  • Sieghart W, Karobath M (1980) Molecular heterogeneity of benzodiazepine receptors. Nature 286: 285–287

    Article  CAS  PubMed  Google Scholar 

  • Sigel E, Stephenson FA, Mamalaki C, Barnard EA (1983) A γ-aminobutyric acid/benzodiazepine receptor complex of bovine cerebral cortex. J Biol Chem 258: 6965–6971

    CAS  PubMed  Google Scholar 

  • Strohle A, Romeo E, di Michele F et al (2003) Induced panic attacks shift gamma- aminobutyric acid type A receptor modulatory neuroactive steroid composition in patients with panic disorder: preliminary results. Arch Gen Psychiatry 60: 161–168

    Article  CAS  PubMed  Google Scholar 

  • Study RE, Barker JL (1981) Diazepam and (–)-pentobarbital: fluctuation analysis reveals different mechanisms for potentiation of γ-aminobutyric acid responses in cultured central neurons. Proc Natl Acad Sci USA 78: 7180–7184

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Sur C, Fresu L, Howell O et al (1999) Autoradiographic localization of α5 subunit- containing GABAA receptors in rat brain. Brain Res 822: 265–270

    Article  CAS  PubMed  Google Scholar 

  • Susman J, Klee B (2005) The role of high-potency benzodiazepines in the treatment of panic disorder. Prim Care Companion J Clin Psychiatry 7: 5–11

    Article  PubMed Central  PubMed  Google Scholar 

  • Thompson SA, Whiting PJ, Wafford KA (1996) Barbiturate interactions at the human GABAA receptor: dependence on receptor subunit combination. Br J Pharmacol 117: 521–527

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Vasile RG, Bruce SE, Goisman RM et al (2005) Results of a naturalistic longitudinal study of benzodiazepine and SSRI use in the treatment of generalized anxiety disorder and social phobia. Depress Anxiety 22(2): 59–67

    Article  PubMed Central  PubMed  Google Scholar 

  • Wallner M, Hanchar HJ, Olsen RW (2003) Ethanol enhances α4β3δ and α6β3δ γ-aminobutyric acid type A receptors at low concentrations known to affect humans. Proc Natl Acad Sci USA 100: 15218–15223

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Wetzel H, Benkert O (1988) Lorazepam for treatment of catatonic symptoms and severe psychomotor retardation. Am J Psychiatry 145: 1175–1176

    CAS  PubMed  Google Scholar 

  • Wetzel H, Heuser I, Benkert O (1987) Stupor and affective state: alleviation of psychomotor disturbances by lorazepam and recurrence of symptoms after Ro 15–1788. J Nerv Ment Dis 175: 240–242

    Article  CAS  PubMed  Google Scholar 

  • Wetzel H, Heuser I, Benkert O (1988) Benzodiazepines for catatonic symptoms, stupor, and mutism. Pharmacopsychiatry 21: 394–395

    Article  CAS  PubMed  Google Scholar 

  • Wieland H, Lüddens H, Seeburg PH (1992) A single histidine in GABAA receptors is essential for benzodiazepine agonist binding. J Biol Chem 267: 1426–1429

    CAS  PubMed  Google Scholar 

  • Wisden W, Laurie DJ, Monyer H, Seeburg PH (1992) The distribution of 13 GABAA receptor subunit mRNAs in the rat brain. I. Telencephalon, diencephalon, mesencephalon. J Neurosci 12: 1040–1062

    CAS  PubMed  Google Scholar 

  • Zohar J, Westenberg HG (2000) Anxiety disorders: a review of tricyclic antidepressants and selective serotonin reuptake inhibitors. Acta Psychiatr Scand Suppl 403: 39–49

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Psychiatrische Klinik, Johannes-Gutenberg-Universität Mainz, Untere Zahlbacher Straße 8, 55131, Mainz

    Univ.-Prof. Dr. Hartmut Lüddens

Authors
  1. Univ.-Prof. Dr. Hartmut Lüddens
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Klinik für Psychiatrie, Psychotherapie und Psychosomatik, Pauwelsstr. 30, 52074, Aachen

    Gerhard Gründer

  2. Luisenstr. 19, 55124, Mainz

    Otto Benkert

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Lüddens, H. (2012). Anxiolytika und Hypnotika. In: Gründer, G., Benkert, O. (eds) Handbuch der psychiatrischen Pharmakotherapie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-19844-1_56

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-19844-1_56

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-19843-4

  • Online ISBN: 978-3-642-19844-1

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation